Differences between mental disorders of French Canadians and British Canadians.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000437:Alcoholism / Q000453:epidemiology*; D001714:Bipolar Disorder / Q000453:epidemiology; D002170:Canada; D002707:Chlordiazepoxide / Q000627:therapeutic use; D003398:Craniosynostoses / Q000235:genetics; D003431:Cross-Cultural Comparison; D003704:Dementia / Q000453:epidemiology; D003863:Depression / Q000453:epidemiology; D004316:Doxepin / Q000627:therapeutic use; D005006:Ethnicity; D005260:Female; D005602:France; D006801:Humans; D007902:Length of Stay; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy / Q000453:epidemiology* / Q000628:therapy; D008875:Middle Aged; D009497:Neurotic Disorders / Q000453:epidemiology; D009790:Occupations; D011569:Psychiatric Status Rating Scales; D012424:Rural Population; D012559:Schizophrenia / Q000453:epidemiology; D012737:Sex Factors; D006113:United Kingdom
D004316:Doxepin; D002707:Chlordiazepoxide